In a prospective validation study of utilizing EsophaCap, a four-gene methylation panel (p16/CDKN2A, NELL1, AKAP12, TAC1) analyzed with the methylation-on-beads method discriminated BE from controls with high accuracy (sensitivity 78.6%; specificity 92.8%). Here, CDKN2A is linked to Barrett esophagus.